This is an old revision of this page, as edited by Snubcube (talk | contribs) at 07:52, 13 August 2010 (Replace png with svg). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 07:52, 13 August 2010 by Snubcube (talk | contribs) (Replace png with svg)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff){{Drugbox| |IUPAC_name = N--N'-(2-{thio}ethyl)guanidine | image=Impromidine.svg | CAS_number=55273-05-7 | ATC_prefix=none | ATC_suffix= | PubChem= 41376 | IUPHAR_ligand = 1226 | DrugBank= | smiles = Cc2ncnc2CSCCNC(N)=NCCCc1cncn1 | C=14 | H=23 | N=7 | S=1 | molecular_weight = 321.44 g/mol | bioavailability= | metabolism = | elimination_half-life= | excretion = | pregnancy_category = | legal_status = | routes_of_administration= }} Impromidine (INN) is a highly potent and specific histamine H2 receptor agonist.
It has been used diagnostically as a gastric secretion indicator.
See Histamine agonists.
References
- Durant G, Duncan W, Ganellin C, Parsons M, Blakemore R, Rasmussen A (1978). "Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors". Nature. 276 (5686): 403–5. doi:10.1038/276403a0. PMID 714166.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |